坐骨神经萎缩是慢性肢体威胁性缺血患者伤口愈合不良的危险因素
这项单中心回顾性研究纳入2015至2020年在九州医疗中心成功行血运重建的188例(226条肢体)组织缺损型慢性肢体威胁性缺血患者,用CT测量坐骨神经横截面积(CSA),以23.6 mm²为预测伤口愈合的截断值,将患者分为正常组(147条)和萎缩组(79条)。萎缩组6个月伤口愈合率为27.3%,低于正常组的87.3%(P < .001),3年无截肢生存率为20.0% vs 59.3%(P < .001),3年总生存率为57.8% vs 71.3%(P = .022)。多因素分析显示坐骨神经萎缩是血运重建后伤口愈合不良的独立危险因素(HR 5.08,P < .001)。
要点
- 坐骨神经CSA截断值23.6 mm²预测伤口愈合的AUC为0.81,敏感度0.85、特异度0.71。
- 萎缩组6个月伤口愈合率27.3% vs 正常组87.3%(P < .001)。
- 多因素分析中坐骨神经萎缩与伤口愈合不良独立相关(HR 5.08,P < .001)。
核心结论
- 坐骨神经萎缩与慢性肢体威胁性缺血患者较差的伤口愈合、无截肢生存率和总生存率相关。
- 坐骨神经评估可能有助于指导肢体挽救适应证的决策。
研究设计与样本
- 单中心、回顾性研究,纳入2015至2020年在九州医疗中心成功行血运重建的组织缺损型慢性肢体威胁性缺血患者。
- 共188例患者(226条肢体),用CT在胫神经与腓神经分叉上方测量坐骨神经横截面积(CSA)。
- 用受试者工作特征分析确定预测伤口愈合的CSA截断值,并据此将患者分为正常组(n = 147)和萎缩组(n = 79)。
主要发现
- 平均坐骨神经CSA为27.5 ± 0.7 mm²;CSA截断值23.6 mm²(曲线下面积 = 0.81;敏感度 = 0.85;特异度 = 0.71)。
- 萎缩组较正常组有更高的非步行状态比例(38% vs 23%;P = .029)、缺血性心脏病比例(47% vs 28%;P = .008)、脑血管病比例(50% vs 35%;P = .045)、终末期肾病比例(55% vs 37%;P = .024),以及更低的血清白蛋白(3.3 ± 0.06 vs 3.6 ± 0.05;P = .001)。
- 6个月伤口愈合率正常组为87.3%,萎缩组为27.3%(P < .001)。
- 3年无截肢生存率正常组为59.3%,萎缩组为20.0%(P < .001);3年总生存率正常组为71.3%,萎缩组为57.8%(P = .022)。
- 与伤口愈合不良相关的因素包括年龄(风险比[HR] 1.01;P = .045)、低血清白蛋白(HR 1.80;P = .001)、缺血性心脏病(HR 1.75;P = .002)、终末期肾病(HR 1.71;P = .002)和坐骨神经萎缩(HR 5.21;P < .001);多因素分析确定年龄(HR 1.02;P = .012)和坐骨神经萎缩(HR 5.08;P < .001)为血运重建后伤口愈合不良的独立危险因素。
关键数值与推荐
- 全球血管指南建议对不适合血运重建的患者行一期截肢。
- 坐骨神经CSA截断值23.6 mm²用于分组:大于该值为正常组,小于该值为萎缩组。
临床怎么用
- 作者认为坐骨神经评估可能有助于指导肢体挽救适应证的决策。
- 全球血管指南建议对不适合血运重建的患者行一期截肢。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with chronic limb-threatening ischemia (CLTI) typically undergo revascularization as the standard treatment. However, some still require major amputations post-revascularization. Because revascularization is invasive and costly, avoiding it may benefit patients with low likelihoods of wound healing. The Global Vascular Guidelines suggest primary amputation for patients unsuited to revascularization. Although previous research has linked frailty to limb prognosis, skeletal and bone frailties impact survival rather than limb outcomes. This study examines the association between sciatic nerve atrophy and limb prognosis in patients with CLTI. METHODS: This single-center, retrospective study included patients with tissue loss CLTI who underwent successful revascularizations at Kyushu Medical Center (2015-2020). Sciatic nerve cross-sectional areas (CSAs) were measured using computed tomography scans above the bifurcation of the tibial and peroneal nerves. The CSA cutoff value for predicting wound healing was established using receiver operating characteristic analysis. Patients were grouped based on whether their CSA was larger (normal) or smaller (atrophy) than CSA cutoff value. Outcomes assessed included wound healing rates, amputation-free survival (AFS), and overall survival (OS). RESULTS: Among 188 patients (226 limbs), the mean sciatic nerve CSA was 27.5 ± 0.7 mm2. A CSA cutoff of 23.6 mm2 (area under the curve = 0.81; sensitivity = 0.85; specificity = 0.71) was identified. Patients were categorized into normal (n = 147) and atrophy (n = 79) groups. The atrophy group had higher rates of nonambulatory status (38% vs 23%; P = .029), ischemic heart disease (47% vs 28%; P = .008), cerebrovascular disease (50% vs 35%; P = .045), end-stage renal disease (55% vs 37%; P = .024), and lower serum albumin (3.3 ± 0.06 vs 3.6 ± 0.05; P = .001). Six-month wound healing rates were 87.3% in the normal group vs 27.3% in the atrophy group (P < .001). Three-year AFS was 59.3% in the normal group vs 20.0% in the atrophy group (P < .001), and 3-year OS was 71.3% vs 57.8% (P = .022). Factors associated with impaired wound healing included age (hazard ratio [HR], 1.01; P = .045), low serum albumin (HR, 1.80; P = .001), ischemic heart disease (HR, 1.75; P = .002), end-stage renal disease (HR, 1.71; P = .002), and sciatic nerve atrophy (HR, 5.21; P < .001). Multivariate analysis identified age (HR, 1.02; P = .012) and sciatic nerve atrophy (HR, 5.08; P < .001) as independent risk factors for impaired wound healing after revascularizations. CONCLUSIONS: Sciatic nerve atrophy correlates with poorer wound healing, AFS, and OS in patients with CLTI. Sciatic nerve assessment may guide decisions regarding limb salvage eligibility.
引用
- Matsubara Y, Furuyama T, Onohara T, et al. Sciatic nerve atrophy as a risk factor for impaired wound healing in patients with chronic limb-threatening ischemia. J Vasc Surg. 2025. PMID: 39971142. doi:10.1016/j.jvs.2025.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。